Risk factor
Very poor trading liquidity
Profitability factor
Solid dividends
About
Based in Taoyuan City, Taiwan, and established in 2009, Crystalvue Medical Corporation operates internationally, specializing in the design, production, and distribution of ophthalmic medical devices. Their comprehensive product range encompasses instruments like retinal cameras, tonometers, and lens edgers, in addition to various gastroenterology provisions.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITD.
Target Price
The average target price of 6527.TWO is 173 and suggests 140% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in